Showing 1071-1080 of 1197 results for "".
- ASPS Survey: Cosmetic Surgery Regulation Challenges Exist Across the Globehttps://modernaesthetics.com/news/asps-survey-cosmetic-surgery-regulation-challenges-exist-across-the-globe/2473473/Most countries have a regulatory entity, but some face regulations that vary by region or lack a regulatory agency entirely, according to a survey of 2,553 plastic surgeons across 22 countries conducted by The American Society of Plastic Surgeons (ASPS) Global Leadership Forum (GLF).&n
- Nulastin Taps Felipe Jimenez, PhD, for Chief Science Officerhttps://modernaesthetics.com/news/nulastin-taps-felipe-jimenez-phd-for-chief-science-officer/2473462/Felipe Jimenez, PhD, is Nulastin’s new Chief Science Officer. Formerly of Benchmark Cosmetic Laboratories (a KDC/One company) and Guthy-Renker, Mr. Jimenez holds more than 30 patents on elastin regeneration. "This is a dream come true having F
- News You Can Use: RVL Rolls Out New Prescription E-commerce Platform, ELEVATEhttps://modernaesthetics.com/news/news-you-can-use-rvl-rolls-out-new-prescription-e-commerce-platform-elevate/2473442/RVL Pharmaceuticals is launching a prescription e-commerce platform. ELEVATE is a secure subscription platform that allows both providers and patients to purchase RVL products. The platform comprises RVL-initiated auto refills and unlocks additional&nb
- Sentient Introduces Tixel in the UShttps://modernaesthetics.com/news/sentient-introduces-tixel-in-the-us/2473416/Sentient is rolling out Sentient Tixel in the US. Sentient Tixel uses thermal-mechanical action technology to resurface skin. Tixel technology uniquely combines heat with the forward motion of a medical-grade titanium tip without the use of lasers, radiation, ultrasound, or needles.
- Cutera Update: Agreements Made with Pura Vida and RTW; New Board Members Appointedhttps://modernaesthetics.com/news/cutera-update-agreements-with-pura-vida-and-rtw/2473414/Cutera announced that it has entered into cooperation agreements with two of its largest stockholders, Pura Vida Investments LLC and RTW Investments LP, which collectively own more than 15% of the company’s outstanding shares. Pursuant to the agreements, Cutera will appo
- Sculptra Scores FDA Nod for Cheek Wrinkleshttps://modernaesthetics.com/news/sculptra-scores-fda-nod-for-cheeks/2473402/The U.S. Food and Drug Administration (FDA) has approved Sculptra (injectable poly-L-lactic acid (PLLA-SCA)) for the correction of fine lines and wrinkles in the cheek area. Sculptra is the first FDA-approved PLLA collagen stimulator that helps stimulate natural collagen produ
- Beautiful Singer Christina Aguilera Named New Xeomin Brand Partnerhttps://modernaesthetics.com/news/beautiful-singer-christina-aguilera-named-new-xeomin-brand-partner/2473369/Christina Aguilera is the latest Xeomin (incobotulinumtoxinA) brand partner as Merz Aesthetics expands its ‘Beauty on Your Terms’ marketing campaign. Launched in August 2022, the campaign features multiple music icons in support of Xeomin.
- Perfect Corp.’s New Global Beauty Trend Report Highlights Rise in Use of AI Skin Technologyhttps://modernaesthetics.com/news/perfect-corps-new-global-beauty-trend-report-highlights-rise-in-use-of-ai-skin-technology/2473328/Perfect Corp.’s latest Global Beauty Trend Report, “The Rise of AI Skin Technology” documents the rise in consumer interest in skin car
- Hugel Resubmits BLA for Botulaxhttps://modernaesthetics.com/news/hugel-resubmits-bla-for-botulax/2473314/Hugel resubmitted the BLA for its botulinum toxin called Botulax for smoothing glabellar lines to the U.S. FDA. Hugel had received a Complete Response Letter (CRL) from the U.S. FDA last March after submitting the BLA for Botulax (50 and 100 units) to advance into the U.S. market i
- ASDS News: Patients Love Galderma's Investigational Liquid Botulinum Toxinhttps://modernaesthetics.com/news/asds-news-patients-love-galdermas-investigational-liquid-botulinum-toxin/2473312/Galderma's investigational ready-to-use liquid botulinum toxin RelabotulinumtoxinA scored high patient satisfaction and psychological well-being ratings for the treatment of glabellar lines and lateral canthal lines in addition to previously reported safety and efficacy, according to pre